IGFBP2 and central nervous system cancer: We revealed that only SRSF1, but not IGFBP2 and EMP3, was markedly reduced by miR-6760-5p mimics but increased by miR-6760-5p inhibitors in glioma tumor cells, suggesting that SRSF1 is the direct target of miR-6760-5p (Figure 4B-4C, Figure S4A-S4B and Table S6).